![GILEAD SCIENCES, INC. [GILD] reports annual net loss of $5.6 billion](/_next/image?url=https%3A%2F%2F10kinfo-appdata.s3.us-west-2.amazonaws.com%2Fedgar0105%2FCompanyLogos%2FUS%2FGILD.png&w=3840&q=75)
GILEAD SCIENCES, INC. [GILD] reports annual net loss of $5.6 billion
Company Reports Revenue of $27.1 billion
GILEAD SCIENCES, INC. [GILD] has reported a net loss of $5.6 billion for year ended Dec 31, 2023.
The Company said in a filing before the Securities and Exchange Commission that its total revenue for the year was $27.1 billion
Based in FOSTER CITY, California, GILEAD SCIENCES, INC. operates in the MANUFACTURING sector.
In the annual report for the fiscal year ending December 31, 2023, Gilead Sciences Inc. reported total revenues of $27.1 billion, slightly lower than the $27.3 billion reported in the previous year, indicating a marginal decrease in revenue. The cost of goods sold for the year was $6.5 billion, higher than the $6.6 billion reported in the prior year.
Operating income for the year was $7.6 billion, showing an increase from the $7.3 billion reported in the previous year. The company reported a net income of $5.6 billion for the current year, up from $4.6 billion in the previous year.
